# USA Nicotine Pouch Market

---

## Market Overview

# CHAPTER 1 - Market Overview

The USA Nicotine Pouch Market operates through branded manufacturers, wholesalers, convenience retailers, mass merchants, specialty stores, and age-verified digital channels. The addressable switching pool remains substantial: 28.8 million U.S. adults smoked cigarettes in 2022, while 67.7% wanted to quit. Pouches compete through discreet use, nicotine delivery, flavor, strength, can format, retail visibility, and repeat-purchase economics.

Supply and distribution are concentrated around established tobacco manufacturing and logistics corridors in Kentucky, North Carolina, Virginia, and expanding capacity in Colorado. A USD 600 million ZYN facility in Aurora was designed to create 500 direct jobs and 1,000 indirect jobs. Domestic production reduces stock shortages, supports retailer replenishment, and provides export capacity as international pouch demand scales.

Federal market access is controlled through the FDA premarket tobacco product application pathway. By December 2025, 26 nicotine pouch products from two manufacturers had received marketing granted orders. Federal law prohibits nicotine sales to persons younger than 21, while retailers must verify photographic identification for customers under 30. Authorization creates a meaningful compliance and capital barrier for entrants.

The category is replacing part of the declining traditional oral tobacco revenue pool rather than depending solely on new nicotine initiation. Nicotine pouches reached 53.3% of U.S. oral tobacco retail volume in 2025, ten percentage points above 2024. ZYN shipments reached 794 million cans, while on! shipped 177.8 million cans, demonstrating a rapid structural reallocation of shelf space and manufacturer investment.

## KPIs at a Glance

* Market Value: USD 5.75 Bn (2025)
* Dominant Region: Southern United States (2025)
* Dominant Segment: High-strength mint pouches (fastest growing)
* Total Number of Players: 25+

## Future Outlook

The market is projected to expand from USD 5.75 Bn in 2025 to USD 17.65 Bn by 2031, representing a forecast CAGR of 20.6%. Growth is expected to moderate from the 49.1% historical CAGR recorded during 2020-2025 as the category develops a larger revenue base. Volume is forecast to reach 3.09 billion cans by 2031, supported by greater convenience-store productivity, FDA-authorized portfolio extensions, domestic capacity, higher adult awareness, and conversion from cigarettes, moist snuff, snus, and vapor products. Forecast performance remains sensitive to flavor restrictions, taxation, marketing controls, authorization timing, and youth-use trends.

Retail value is forecast to reach USD 15.40 Bn by 2030 before advancing further in 2031. The modeled blended shelf value increases from USD 4.87 per can in 2025 to USD 5.71 by 2031 as premium products, higher-strength variants, child-resistant packaging, and brand-led innovation improve mix. Base-case expansion assumes nicotine pouches reach 76.0% of oral-category can volume by 2031. A constrained regulatory scenario produces a USD 14.60 Bn market, while accelerated authorization, switching, and capacity could support USD 21.20 Bn. Operators therefore need balanced portfolios, compliant adult targeting, disciplined pricing, and resilient channel coverage.

| Future Outlook KPI | Value |
| --- | --- |
| 2025 Market Size | USD 5.75 Bn |
| 2030 Market Size | USD 15.40 Bn |
| 2031 Market Size | USD 17.65 Bn |
| Historical CAGR, 2020-2025 | 49.1% |
| Forecast CAGR, 2026-2031 | 20.6% |
| 2031 Forecast Volume | 3.09 Bn cans |
| 2031 Blended Retail Value | USD 5.71 per can |

---

## Scope of the Report

# CHAPTER 2 - Scope of the Market

* **Geographic Coverage:** United States
* **Historical Period:** 2020-2025
* **Base Year:** 2025
* **Forecast Period:** 2026-2031
* **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Nicotine Strength, Customer Type, Use Occasion, Distribution Channel, Packaging Format, Geography)
* **Companies Covered:** Top 10 key players profiled
* **Currency & Units:** USD, values expressed in USD Mn/Bn

### Segmentation Data Tree

* Product Type
 + Tobacco-derived nicotine pouches
 - Mint and wintergreen varieties
 - Non-mint flavored varieties
 + Synthetic nicotine pouches
 - Standard-strength formulations
 - High-strength formulations
 + Other tobacco-leaf-free formulations
 - Plant-fiber pouches
 - Alternative delivery formulations
* Nicotine Strength
 + Low strength, up to 3 mg
 - 1.5-2 mg per pouch
 - 3 mg per pouch
 + Standard strength, above 3-6 mg
 - 4 mg per pouch
 - 6 mg per pouch
 + High strength, above 6-9 mg
 - 7-8 mg per pouch
 - 9 mg per pouch
 + Extra-high strength, above 9 mg
 - 10-12 mg per pouch
 - Above 12 mg per pouch
* Customer Type
 + Adult cigarette smokers
 - Daily smokers
 - Occasional smokers
 + Adult traditional oral users
 - Moist snuff users
 - Snus and chewing tobacco users
 + Adult vapor and multi-product users
 - Exclusive vapor users
 - Poly-product users
 + Former adult tobacco users
 - Recently former users
 - Long-term former users
* Use Occasion
 + Routine daily use
 - Morning consumption
 - Daytime repeat consumption
 + Discreet indoor use
 - Workplace use
 - Travel and transport use
 + Social and recreational use
 - Events and entertainment
 - Outdoor activities
 + Transition from combustible products
 - Complete product switching
 - Temporary dual-product use
* Distribution Channel
 + Convenience stores and gas stations
 - National and regional chains
 - Independent convenience stores
 + Food, drug, and mass retail
 - Supermarkets and drugstores
 - Mass merchants and warehouse clubs
 + Tobacco specialty retail
 - Smoke shops
 - Vape and alternative nicotine stores
 + Digital direct-to-consumer
 - Brand-owned websites
 - Age-verified online retailers
* Packaging Format
 + Standard single cans
 - 15-pouch cans
 - 20-pouch cans
 + Multipack formats
 - Two-to-five can packs
 - Six-or-more can packs
 + Child-resistant cans
 - Certified child-resistant closure
 - Integrated safety-lid format
* Geography
 + Southern United States
 - South Atlantic
 - East and West South Central
 + Midwestern United States
 - East North Central
 - West North Central
 + Northeastern United States
 - New England
 - Mid-Atlantic
 + Western United States
 - Mountain states
 - Pacific states

---

## Market Trajectory

# CHAPTER 3 - Market Size & Growth Trajectory

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

### Historical and Projected Market Size

| Year | Market Size (USD Mn) |
| --- | --- |
| 2020 | 780 |
| 2021 | 1,150 |
| 2022 | 1,690 |
| 2023 | 2,550 |
| 2024 | 3,950 |
| 2025 | 5,750 |
| 2026F | 7,350 |
| 2027F | 9,150 |
| 2028F | 11,150 |
| 2029F | 13,250 |
| 2030F | 15,400 |
| 2031F | 17,650 |

### YoY Growth Rate

| Year | YoY Growth Rate (%) |
| --- | --- |
| 2021 | 47.4 |
| 2022 | 47.0 |
| 2023 | 50.9 |
| 2024 | 54.9 |
| 2025 | 45.6 |
| 2026F | 27.8 |
| 2027F | 24.5 |
| 2028F | 21.9 |
| 2029F | 18.8 |
| 2030F | 16.2 |
| 2031F | 14.6 |

### Market Value vs Volume Growth

| Year | Market Value Growth (%) | Can Volume Growth (%) |
| --- | --- | --- |
| 2020 | - | - |
| 2021 | 47.4 | 42.1 |
| 2022 | 47.0 | 40.7 |
| 2023 | 50.9 | 43.4 |
| 2024 | 54.9 | 50.5 |
| 2025 | 45.6 | 43.9 |
| 2026F | 27.8 | 22.9 |
| 2027F | 24.5 | 21.4 |
| 2028F | 21.9 | 18.8 |
| 2029F | 18.8 | 15.8 |
| 2030F | 16.2 | 13.6 |

### Historical Market Performance, 2020-2025

Historical growth peaked at 54.9% in 2024 as improved supply, wider retail placement, and brand awareness lifted annual category volume to approximately 820 million cans. The modeled trough was still a high 45.6% in 2025, reflecting normalization after the category achieved larger scale. Can volume expanded at a 44.1% CAGR during 2020-2025, while price and mix added approximately 5.0 percentage points to cumulative value growth. Retail concentration remained high, with premium national brands controlling the majority of sales and convenience stores functioning as the main trial, visibility, and replenishment channel.

### Forecast Market Outlook, 2026-2031

Forecast growth gradually moderates from 27.8% in 2026 to 14.6% in 2031, producing a six-year CAGR of 20.6%. Annual volume reaches approximately 3.09 billion cans in 2031, equivalent to 12.4% volume growth in the terminal year. The blended value per can rises from USD 5.07 in 2026 to USD 5.71 in 2031 as premium brands, higher nicotine strengths, and improved package formats expand. The forecast assumes FDA-authorized ranges gain share, oral-category conversion continues, and manufacturers avoid prolonged supply shortages while complying with adult-targeting and youth-prevention requirements.

---

## Market Breakdown

# CHAPTER 4 - Detailed Market Data and Performance Indicators

| Year | Market Size (USD Mn) | YoY Growth (%) | Category Volume (Mn cans) | Blended Retail Value (USD/can) | Nicotine Pouch Share of Oral Category (%) | Period |
| --- | --- | --- | --- | --- | --- | --- |
| 2020 | 780 | - | 190 | 4.11 | 7.0 | Historical |
| 2021 | 1,150 | 47.4 | 270 | 4.26 | 10.5 | Historical |
| 2022 | 1,690 | 47.0 | 380 | 4.45 | 16.0 | Historical |
| 2023 | 2,550 | 50.9 | 545 | 4.68 | 26.0 | Historical |
| 2024 | 3,950 | 54.9 | 820 | 4.82 | 43.3 | Historical |
| 2025 | 5,750 | 45.6 | 1,180 | 4.87 | 53.3 | Base Year |
| 2026F | 7,350 | 27.8 | 1,450 | 5.07 | 59.0 | Forecast and Latest Operating KPIs |
| 2027F | 9,150 | 24.5 | 1,760 | 5.20 | 64.0 | Forecast and Industry Outlook |
| 2028F | 11,150 | 21.9 | 2,090 | 5.33 | 68.0 | Forecast and Industry Outlook |
| 2029F | 13,250 | 18.8 | 2,420 | 5.48 | 71.0 | Forecast and Industry Outlook |
| 2030F | 15,400 | 16.2 | 2,750 | 5.60 | 74.0 | Forecast and Industry Outlook |
| 2031F | 17,650 | 14.6 | 3,090 | 5.71 | 76.0 | Forecast and Industry Outlook |

### Category Volume

Modeled volume reached 1.18 billion cans in 2025. The benchmark reconciles 794 million ZYN shipments, 177.8 million on! shipments, challenger-brand retail shares, distributor inventories, and channel sell-through. Volume is forecast to exceed 3.0 billion cans in 2031 as national convenience distribution and repeat purchase frequency rise. Premium national brands, state taxes, freight, retailer margins, and promotional intensity create wide shelf-price dispersion. The model assumes annual price and mix increases of approximately 2.7% during 2026-2031, below historical category-value growth. Share is modeled at 76.0% by 2031 as moist snuff and other traditional oral formats decline. The outcome depends on regulatory continuity and successful adult conversion rather than youth or non-user initiation.

---

## Market Segmentation

# CHAPTER 5 - Market Segmentation Framework

| Segmentation KPI | Assessment |
| --- | --- |
| Number of Primary Dimensions | 7 |
| Dominant Commercial Dimension | Product Type |
| Fastest-Growing Dimension | Nicotine Strength |
| Highest-Revenue Channel | Convenience stores and gas stations |

### Segment Definitions and Strategic Relevance

| Primary Dimension | Sub-Segments | Commercial Relevance |
| --- | --- | --- |
| Product Type | Tobacco-derived nicotine pouches; Synthetic nicotine pouches; Other tobacco-leaf-free formulations | Determines regulatory history, ingredient positioning, manufacturing requirements, consumer trust, and eligibility for product-specific marketing orders. |
| Nicotine Strength | Low strength up to 3 mg; Standard strength above 3-6 mg; High strength above 6-9 mg; Extra-high strength above 9 mg | Influences repeat use, switching suitability, price architecture, consumer segmentation, risk scrutiny, and portfolio spacing. |
| Customer Type | Adult cigarette smokers; Adult traditional oral users; Adult vapor and multi-product users; Former adult tobacco users | Supports compliant targeting, cohort-level demand forecasting, conversion analysis, and differentiated product propositions. |
| Use Occasion | Routine daily use; Discreet indoor use; Social and recreational use; Transition from combustible products | Determines pouch duration, flavor selection, packaging portability, purchase frequency, and channel preference. |
| Distribution Channel | Convenience stores and gas stations; Food, drug, and mass retail; Tobacco specialty retail; Digital direct-to-consumer | Defines retail margins, promotional requirements, age-verification controls, geographic reach, and replenishment economics. |
| Packaging Format | Standard single cans; Multipack formats; Child-resistant cans | Affects unit economics, compliance, accidental-exposure prevention, shelf productivity, and consumer stock-up behavior. |
| Geography | Southern United States; Midwestern United States; Northeastern United States; Western United States | Captures differences in tobacco prevalence, taxes, flavor restrictions, convenience density, demographics, and brand performance. |

### Key Segmentation Takeaways

* Mint and wintergreen varieties remain central to mainstream retail demand, but fruit, citrus, coffee, cinnamon, and tobacco variants support differentiation.
* Standard-strength products remain the volume foundation, while high-strength variants improve portfolio coverage among experienced adult nicotine consumers.
* Convenience retail provides the strongest combination of traffic, tobacco-category adjacency, point-of-sale visibility, and immediate replenishment.
* Child-resistant packaging is moving from a differentiator toward an expected compliance capability for newly authorized products.
* Regional strategy must account for local flavor rules, excise taxes, age-verification enforcement, and differences in combustible and oral tobacco use.

---

## Regional Analysis

# CHAPTER 6 - Regional Analysis and Relevant Country Comparison

* **Focus Country Ranking:** 1st
* **Focus Country Market Size:** USD 5.75 Bn (2025)
* **Focus Country CAGR:** 20.6% (2026-2031)

| Country | Market Size (USD Mn, 2025) | CAGR, 2026-2031 (%) | Estimated Annual Volume (Mn cans, 2025) | Minimum Legal Purchase Age (years) |
| --- | --- | --- | --- | --- |
| United States | 5,750 | 20.6 | 1,180 | 21 |
| Sweden | 1,000 | 10.5 | 210 | 18 |
| United Kingdom | 820 | 22.0 | 165 | 18 |
| Germany | 460 | 24.0 | 85 | 18 |
| Canada | 380 | 18.0 | 70 | 18-19 |
| Denmark | 310 | 11.0 | 62 | 18 |

### Market Position

The United States ranks first among the selected markets, supported by 1.18 billion modeled cans in 2025 and ZYN shipments of 794 million cans. Its retail scale exceeds the combined value of the five selected peers. 

### Growth Advantage

The U.S. forecast CAGR of 20.6% exceeds the 17.1% weighted average across the selected peers. The advantage reflects lower current adult penetration than Nordic markets and faster oral-category conversion. 

### Competitive Strengths

The United States combines a 26-product authorized portfolio, a federal purchase age of 21, and USD 600 million of announced ZYN capacity investment, creating scale, compliance, and manufacturing advantages. 

Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.

---

## Growth Drivers

### Growth Drivers, Challenges & Opportunities

## Growth Drivers

#### 1. Large Adult Switching and Cessation-Interest Pool

The market addresses **28.8 million adult cigarette smokers (2022, United States)**, of whom **67.7% wanted to quit**, creating a large potential pool for authorized non-combustible alternatives when consumers switch completely. 

* **53.3% of adults who smoked attempted to quit (2022, United States)**, indicating repeated demand for alternatives, although nicotine pouches are not FDA-approved cessation medicines. 
* Only **8.8% recently quit successfully (2022, United States)**, showing why product switching, behavioral support, and regulated cessation therapies remain strategically relevant. 
* Current pouch use was highest among people with a history of smoking or smokeless tobacco use, supporting adult-conversion targeting rather than broad non-user acquisition. 

#### 2. Rapid Oral-Category Conversion and Retail Velocity

Nicotine pouches reached **53.3% of U.S. oral tobacco volume (2025)**, up **10.0 percentage points**, demonstrating that growth is reallocating established oral-category shelf space and manufacturer resources. 

* ZYN shipments reached **794 million cans (2025, United States)**, approximately 37% above 2024, confirming continued scale despite a substantially larger base. 
* on! shipments reached **177.8 million cans (2025, United States)**, an increase of 10.9%, preserving a meaningful challenger position. 
* FDA-reviewed evidence indicated that monthly nicotine pouch sales more than tripled during **2021-2024**, validating the category’s broader multi-brand momentum. 

#### 3. Regulatory Formalization and Domestic Capacity

The authorized portfolio expanded to **26 nicotine pouch products (December 2025, United States)**, while a **USD 600 million** Colorado facility added a clear pathway for higher compliant supply. 

* The first **20 ZYN products** received marketing granted orders in January 2025 across ten varieties and two nicotine strengths. 
* Six on! PLUS products received orders in December 2025, including **6 mg and 9 mg** variants with certified child-resistant packaging. 
* The Aurora investment was expected to create **500 direct and 1,000 indirect jobs**, improving supply resilience and potential export capacity. 

## Market Challenges

#### 1. Youth Use, Flavor Appeal, and Addiction Scrutiny

Current nicotine pouch use reached **1.8% of U.S. middle and high school students (2024)**, or nearly half a million students, making youth prevention central to authorization, advertising, packaging, and retailer strategy. 

* **22.4% of youth users reported daily use (2024, United States)**, increasing scrutiny of nicotine strength, repeat consumption, and marketing exposure. 
* **85.6% of youth pouch users used flavored products**, led by mint, fruit, and menthol, placing flavor portfolios at the center of policy debate. 
* ZYN was reported by **68.7% of current youth pouch users**, creating disproportionate monitoring and reputational exposure for the category leader. 

#### 2. High Regulatory Barriers and Limited Authorized Portfolio

Only **26 specific products from two manufacturers (December 2025)** appeared on the FDA authorized list, leaving many commercially visible brands exposed to enforcement, delayed innovation, retailer delisting, or unresolved PMTA status. 

* Marketing authorization is product-specific, meaning an order for one strength or flavor does not authorize the rest of a brand family. 
* Authorized products are not described as “FDA approved” and remain harmful and potentially addictive, restricting health and safety messaging. 
* Digital, television, and radio advertising conditions for on! PLUS require careful adult targeting and ongoing reporting of audience demographics. 

#### 3. Fragmented Flavor, Retail, and Age-Verification Rules

By March 2026, **435 jurisdictions and three Native American tribes** had adopted some flavored-tobacco restriction, while **173 jurisdictions** had comprehensive restrictions covering all flavors and product types. 

* Comprehensive policies can include mint, menthol, and wintergreen, creating material exposure for the category’s highest-volume flavor families. 
* Federal law prohibits sales to persons under **21 years**, and retailers must check photo identification for purchasers under 30. 
* State excise taxes and local product definitions vary, requiring jurisdiction-level pricing, assortment, compliance, and distributor-control processes.

## Market Opportunities

#### 1. Authorized Strength and Portfolio Expansion

FDA authorization of **6 mg and 9 mg on! PLUS products (2025)** expands the lawful high-strength segment and demonstrates a route for differentiated nicotine levels, tobacco variants, and safety-focused packaging. 

* The six products cover mint, tobacco, and wintergreen, providing three distinct adult-use propositions at two strengths. 
* Certified child-resistant cans can reduce accidental-exposure risk and may become a broader portfolio standard for manufacturers and retailers. 
* The FDA’s pilot process completed reviews faster than previous applications, offering a potential template for more predictable product innovation. 

#### 2. Convenience-Store Productivity and Challenger Growth

Nicotine pouches represented **56.9% of oral-category volume in Q4 2025**, indicating further scope for retailers to reallocate facings, promotional resources, inventory, and category-management attention from declining traditional oral products. 

* Velo U.S. revenue increased **297% in 2025**, while volume rose 249%, showing that scaled challengers can gain rapidly through national distribution. 
* Grizzly nicotine pouches achieved **1.8% national share by December 2025** after expanded distribution began in August. 
* Private brands can use specialty and digital channels to validate flavor, strength, and repeat economics before pursuing broader retail expansion.

#### 3. Domestic Manufacturing, Exports, and Supply Resilience

The **USD 600 million Aurora facility**, existing Kentucky pouch production, and planned capacity upgrades create opportunities for local sourcing, shorter replenishment cycles, manufacturing employment, and exports to other legal nicotine-pouch markets. 

* The facility was designed for preliminary operations by late 2025 and regular production during 2026. 
* Construction was associated with nearly **5,000 temporary jobs** and almost USD 1 billion of projected economic impact. 
* Higher capacity reduces allocation risk for retailers and enables brands to support new authorized SKUs without disrupting core-product availability.

---

---

## Competitive Landscape

# CHAPTER 8 - Competitive Landscape

### Competitive Landscape Summary

| Competitive KPI | 2025 Assessment |
| --- | --- |
| Category Leader | ZYN, Philip Morris International and Swedish Match USA |
| Modeled Top-3 Brand Concentration | 91.0% of retail value |
| Largest Disclosed Challenger Growth | Velo, U.S. revenue growth of 297% |
| Authorized Manufacturers | 2 manufacturers with 26 products |
| Primary Competitive Battleground | Convenience-store distribution, authorization, strength, flavor, and price |

### Top 10 Company Overview

| Company or Operating Entity | Key U.S. Brand | Headquarters | Founded | 2025 U.S. Positioning or KPI |
| --- | --- | --- | --- | --- |
| Philip Morris International / Swedish Match USA | ZYN | Stamford, Connecticut | 2008 | 794 million cans shipped; around two-thirds retail value share |
| Altria Group / Helix Innovations | on! and on! PLUS | Richmond, Virginia | 1985 | 177.8 million cans shipped; six on! PLUS products authorized |
| British American Tobacco / Reynolds American | Velo and Grizzly | London, United Kingdom | 1902 | Velo reached 13.1% value share; Grizzly reached 1.8% December share |
| Swisher International / Rogue Holdings | Rogue | Jacksonville, Florida | 1861 | Established multi-flavor and multi-strength challenger |
| Turning Point Brands | FRE and ALP | Louisville, Kentucky | - | Expanding physical retail and manufacturing capacity |
| Lucy Goods | Lucy | Los Angeles, California | - | Digital-first premium pouch platform |
| Imperial Brands / Black Buffalo | Black Buffalo | Bristol, United Kingdom | 1901 | Black Buffalo acquisition announced in 2026; over 12,000 stores disclosed in 2024 |
| Sesh Products | Sesh | New York, New York | - | Premium digital and specialty-channel participant |
| Streamline Group | Juice Head ZTN | - | - | Fruit-forward 6 mg and 12 mg pouch portfolio |
| 2ONE Labs | 2ONE | - | - | Specialty and online nicotine-pouch participant |

### Cross-Comparison of Key Competitors

| Brand | Operational KPI 1: 2025 U.S. Volume | Operational KPI 2: 2025 Share Metric | Financial KPI 1: 2025 Growth | Financial KPI 2: Modeled Shelf Price (USD/can) |
| --- | --- | --- | --- | --- |
| ZYN | 794 million cans | 66.7% modeled value share | Approximately 37% shipment growth | 5.25-6.25 |
| on! | 177.8 million cans | 15.4% disclosed volume share; 11.2% modeled value share | 10.9% shipment growth | 4.25-5.50 |
| Velo | - | 13.1% disclosed value share | 297% U.S. revenue growth | 4.50-5.75 |
| Rogue | - | 2.8% modeled value share | - | 4.25-5.50 |
| FRE and ALP | - | 2.0% modeled combined value share | Rapid expansion from a smaller base | 4.50-5.75 |

### Competitive Analysis Covered

* Brand market position and concentration
* Shipment and retail-share benchmarks
* Convenience and specialty channel reach
* Strength and flavor portfolio breadth
* PMTA and marketing-order position
* Domestic capacity and supply reliability
* Pricing and promotional intensity
* Adult-targeting and youth-prevention controls

---

## Key Stakeholders

# CHAPTER 10 - Target Audience

### Investors

Private-equity funds, venture investors, strategic investors, and public-market participants can use the report to assess category growth, regulatory-adjusted valuations, market concentration, emerging-brand scalability, capacity economics, and likely exit or consolidation pathways.

### Corporates

Tobacco, nicotine, consumer-goods, packaging, ingredient, and contract-manufacturing companies can evaluate entry routes, acquisition targets, portfolio gaps, strength architecture, manufacturing requirements, channel strategy, and partnership opportunities.

### Government

Federal, state, and local institutions can use the market analysis to understand authorized supply, youth-use indicators, adult switching, flavor-policy exposure, age-verification requirements, manufacturing investment, taxation, and enforcement priorities.

### Operators

Manufacturers, wholesalers, convenience chains, mass retailers, specialty stores, and digital operators can benchmark assortment, shelf productivity, pricing, inventory turns, adult-targeting controls, local restrictions, and future demand requirements.

### Financial Institutions

Banks, lenders, insurers, and transaction advisers can assess cash-flow durability, working-capital needs, regulatory risk, capacity investment, litigation exposure, borrower concentration, channel dependence, and scenario-based debt-service capability.

### What You’ll Gain

* Consistent historical and forecast market sizing
* Volume, pricing, and oral-category conversion benchmarks
* Seven-dimension commercial segmentation framework
* Regulatory and public-health risk assessment
* Competitive benchmarking of ten market participants
* Base, constrained, and accelerated forecast scenarios
* Decision inputs for investment, entry, pricing, and distribution

---

## Research Methodology

# CHAPTER 11 - Research Methodology

### Phase 1: Data Collection and Validation

#### Secondary Research

* FDA marketing-order database review
* CDC adult and youth surveillance
* Listed-company shipment disclosure reconciliation
* Retail channel and pricing assessment
* State and local policy mapping

#### Primary Research Framework

* Nicotine pouch category directors
* Convenience retail category buyers
* Regulatory affairs and compliance executives
* Adult nicotine consumer research panels

#### Validation and Triangulation

* 284-respondent validation framework
* Brand shipments and shelf checks
* Channel unit economics reconciliation
* Scenario assumptions independently stress-tested

### Phase 2: Market Size Estimation

#### Top-Down Assessment

* U.S. adult nicotine-user population and product-use prevalence
* Oral tobacco category volume and pouch conversion
* FDA, CDC, and institutional market indicators

#### Bottom-Up Modeling

* Manufacturer-level can shipments and retail-share benchmarks
* Channel-specific shelf price, promotion, and retailer margin
* Annual can volume multiplied by blended retail value

#### V02 Market Size Calculator Reconciliation

| Estimation Route | Method | Model Weight |
| --- | --- | --- |
| Supply-Side | Brand shipments, disclosed shares, challenger volumes, and inventory normalization | 50% |
| Operational | Retail doors, can turns, channel mix, shelf prices, and promotional adjustment | 30% |
| Demand-Side | Adult user population multiplied by penetration, annual consumption, and retail value | 20% |

The three routes were reconciled into a base-year estimate rather than anchored to a single published market total. Secondary market estimates were used only for range checking. Company shipment data were adjusted for trade inventory, promotional cans, channel coverage, and differences between shipment volume and consumer sell-through.

#### Forecasting and Scenario Analysis

* Adult smoking prevalence and oral-category switching
* FDA authorization, flavor policy, taxation, and capacity
* Constrained, base, and accelerated projections through 2031

### Phase 3: Primary Research Coverage

#### Scope Item / Segments

The primary research design spans the USA Nicotine Pouch Market value chain from product development and manufacturing through distribution, retail, adult consumption, regulation, and public-health oversight.

* Manufacturers and Brand Owners
* Distributors and Wholesalers
* Retail Channels
* Adult Consumer and Policy Ecosystem

#### Sample Size

The recommended validation design includes 284 respondents across the four segments to support commercially robust cross-checking of market demand, distribution, pricing, regulation, and product-use behavior.

* Manufacturers and Brand Owners - 68 respondents (Category Director, Regulatory Affairs Director)
* Distributors and Wholesalers - 54 respondents (Vice President of Sales, Distribution Manager)
* Retail Channels - 96 respondents (Category Buyer, Store Operations Director)
* Adult Consumer and Policy Ecosystem - 66 respondents (Adult Nicotine Consumer, Tobacco Control Researcher)

#### Forecast Confidence and Scenario Range

| Scenario | 2031 Market Size | Core Conditions |
| --- | --- | --- |
| Constrained | USD 14.60 Bn | Slow authorization, broader flavor restrictions, higher taxation, and reduced retailer assortment |
| Base | USD 17.65 Bn | Steady adult conversion, adequate capacity, selective authorization, and moderate pricing |
| Accelerated | USD 21.20 Bn | Faster authorization, strong complete switching, high retail productivity, and expanded domestic supply |

---

## Frequently Asked Questions

# CHAPTER 12 - Frequently Asked Questions

#### Q: What is the size and growth outlook of the USA Nicotine Pouch Market?

**A:** The market generated an estimated USD 5.75 Bn in retail sales in 2025, based on 1.18 billion cans and a blended value of USD 4.87 per can. It is projected to reach USD 15.40 Bn in 2030 and USD 17.65 Bn in 2031, representing a 20.6% CAGR during 2026-2031. Growth should moderate as the revenue base expands, but volume, price, and mix remain supportive. **Data used:** USD 5.75 Bn in 2025; USD 17.65 Bn in 2031. **So what:** The category remains attractive, but forecasts must include regulatory and youth-use downside scenarios.

#### Q: Which companies lead the U.S. market?

**A:** ZYN is the category leader, with 794 million U.S. cans shipped during 2025 and around two-thirds of retail value. on! shipped 177.8 million cans and held 15.4% volume share, while Velo’s national rollout lifted its disclosed value share to 13.1%. Rogue, FRE, ALP, Grizzly, Lucy, Black Buffalo, Sesh, Juice Head, and other brands form the challenger pool. **Data used:** Top-three modeled value concentration of 91.0%. **So what:** Entrants need regulatory differentiation and focused channel economics rather than undifferentiated national competition.

#### Q: What is the regulatory status of nicotine pouches?

**A:** Nicotine pouches are regulated tobacco products under U.S. federal law, including products containing nicotine from non-tobacco sources. By December 2025, the FDA had authorized 26 specific products: 20 ZYN products and six on! PLUS products. Authorization permits marketing but does not mean a product is safe or “FDA approved.” Federal sales are restricted to adults aged 21 or older. **Data used:** 26 authorized products; two authorized manufacturers. **So what:** Product-specific authorization, marketing controls, and retailer verification are critical components of commercial viability.

#### Q: Are nicotine pouches approved smoking-cessation products?

**A:** Nicotine pouches are not FDA-approved smoking-cessation medicines. FDA-approved cessation options include regulated nicotine-replacement and prescription therapies. The FDA has authorized certain nicotine pouches as tobacco products after population-level review, and in June 2026 granted 20 ZYN products permission to use a specific modified-risk claim concerning complete replacement of cigarettes. The products remain addictive and are not risk-free. **Data used:** 20 modified-risk orders in 2026. **So what:** Manufacturers and retailers must avoid implying therapeutic approval or risk-free use.

#### Q: Which segments offer the strongest commercial opportunities?

**A:** Convenience retail, high-strength authorized products, child-resistant packaging, multipacks, and adult conversion from cigarettes or traditional oral tobacco offer strong commercial potential. Standard 3-6 mg products retain broad relevance, while 6-9 mg options improve coverage among experienced adult users. Mint and wintergreen remain essential but face local-policy exposure. **Data used:** on! PLUS authorization at 6 mg and 9 mg; pouches at 53.3% of oral volume. **So what:** Portfolio growth should balance strength innovation with compliant flavor and geography diversification.

#### Q: What are the most important risks for investors and operators?

**A:** The principal risks are youth adoption, flavor restrictions, PMTA delays or denials, enforcement against unauthorized products, excise-tax increases, litigation, supply concentration, and retailer delisting. In 2024, 1.8% of middle and high school students reported current pouch use, and 22.4% of youth users reported daily use. By March 2026, 435 jurisdictions had some flavored-tobacco restriction. **Data used:** 1.8% youth prevalence; 435 restricted jurisdictions. **So what:** Compliance and youth prevention must be treated as core enterprise capabilities.

#### Q: What capabilities are required to win in this market?

**A:** Winning companies require product-specific regulatory evidence, reliable nicotine and pouch-material sourcing, consistent manufacturing, adult-targeted brand building, retailer relationships, age verification, local-policy intelligence, and disciplined revenue management. Scale improves PMTA economics and distribution, but smaller firms can compete through focused adult cohorts and differentiated use occasions. **Data used:** USD 600 million of announced ZYN capacity; 26 authorized products. **So what:** Sustainable advantage comes from combining compliance, supply reliability, consumer relevance, and channel execution rather than flavor proliferation alone.

---

## Table of Contents

# CHAPTER 14 - Table Of Contents

### Market Report Structure

Comprehensive coverage across three strategic phases — Market Assessment, Go-To-Market Strategy, and Survey — delivering end-to-end insights from market analysis and execution roadmap to customer demand validation.




## Market Assessment Phase

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

### 1. Executive Summary and Approach

### 2. USA Nicotine Pouch Market Overview

#### 2.1 Key Insights and Strategic Recommendations

#### 2.2 USA Nicotine Pouch Market Overview

#### 2.3 Definition and Scope

#### 2.4 Evolution of Market Ecosystem

#### 2.5 Timeline of Key Regulatory Milestones

#### 2.6 Value Chain and Stakeholder Mapping

#### 2.7 Business Cycle Analysis

#### 2.8 Policy and Incentive Landscape

### 3. USA Nicotine Pouch Market Analysis

#### 3.1 Growth Drivers

##### 3.1.1 Growth Drivers, Challenges & Opportunities

##### 3.1.2 Growth Drivers

##### 3.1.3 Rising Consumer Shift Toward Smoke-Free Nicotine Alternatives

##### 3.1.4 Expanding Retail Availability in Convenience Channels

#### 3.2 Market Challenges

##### 3.2.1 Market Challenges

##### 3.2.2 Intense Price Competition from Legacy Tobacco Products

##### 3.2.3 Evolving State-Level Flavor Restrictions

##### 3.2.4 Supply Chain Disruptions in Domestic Manufacturing

#### 3.3 Market Opportunities

##### 3.3.1 Market Opportunities

##### 3.3.2 Premiumization Through Strength and Flavor Innovation

##### 3.3.3 Expansion into Specialty and Online Retail Channels

##### 3.3.4 Strategic Partnerships with Authorized Manufacturers

#### 3.4 Market Trends

##### 3.4.1 Accelerated Adoption of Nicotine Pouches Among Adult Smokers Seeking Alternatives

##### 3.4.2 Growth in Mint and Citrus Flavor Variants Driving Repeat Purchases

##### 3.4.3 Increasing Focus on PMTA-Approved Products for Market Credibility

##### 3.4.4 Shift Toward Higher Nicotine Strengths in the 6mg to 12mg Range

#### 3.5 Government Regulation

##### 3.5.1 FDA PMTA Authorization Requirements for New Nicotine Pouch Brands

##### 3.5.2 Federal Minimum Age of Sale Enforcement at 21 Years

##### 3.5.3 State-Level Restrictions on Youth-Targeted Marketing and Advertising

##### 3.5.4 Proposed Flavor Ban Legislation in Key States Including California and New York

### 4. SWOT Analysis

### 5. Stakeholder Analysis

### 6. Porter's Five Forces Analysis

### 7. USA Nicotine Pouch Market Market Size, 2019-2024

#### 7.1 By Value

#### 7.2 By Volume

#### 7.3 By Average Selling Price

### 8. USA Nicotine Pouch Market Segmentation

#### 8.1 Segment Definitions and Strategic Relevance

#### 8.2 Key Segmentation Takeaways

### 9. USA Nicotine Pouch Market Competitive Analysis

#### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises)

#### 9.2 Cross Comparison of Key Players

##### 9.2.1 Company Name

##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention)

##### 9.2.3 Brand market position and concentration

##### 9.2.4 Shipment and retail-share benchmarks

##### 9.2.5 Convenience and specialty channel reach

##### 9.2.6 Strength and flavor portfolio breadth

##### 9.2.7 PMTA and marketing-order position

##### 9.2.8 Domestic capacity and supply reliability

##### 9.2.9 Pricing and promotional intensity

##### 9.2.10 Adult-targeting and youth-prevention controls

#### 9.3 SWOT Analysis of Top Players

#### 9.4 Pricing Analysis

#### 9.5 Detailed Profile of Major Companies

##### 9.5.1 Category Leader

##### 9.5.2 Modeled Top-3 Brand Concentration

##### 9.5.3 Largest Disclosed Challenger Growth

##### 9.5.4 Authorized Manufacturers

##### 9.5.5 Primary Competitive Battleground

### 10. USA Nicotine Pouch Market End-User Analysis

#### 10.1 Procurement Behavior of Key Ministries

##### 10.1.1 Federal and State Health Agency Purchasing Patterns

##### 10.1.2 Compliance-Driven Procurement for Public Health Programs

##### 10.1.3 Volume Commitments Tied to Youth Prevention Initiatives

##### 10.1.4 Preference for PMTA-Approved Suppliers in Government Tenders

#### 10.2 Corporate Spend on Infrastructure and Energy

##### 10.2.1 Workplace Wellness Program Allocations for Nicotine Alternatives

##### 10.2.2 Corporate Partnerships with Pouch Manufacturers for Employee Benefits

##### 10.2.3 Budgeting for On-Site Vending and Distribution Infrastructure

##### 10.2.4 ROI Tracking on Reduced Smoking-Related Absenteeism

#### 10.3 Pain Point Analysis by End-User Category

##### 10.3.1 Limited Flavor Options in Regulated Markets

##### 10.3.2 Inconsistent Supply Availability Across Regions

##### 10.3.3 High Pricing Sensitivity Among Price-Conscious Adult Users

##### 10.3.4 Concerns Over Long-Term Product Safety Data

#### 10.4 User Readiness for Adoption

##### 10.4.1 High Awareness Levels Among Former Smokers in Urban Areas

##### 10.4.2 Growing Trial Rates in Convenience Store Channels

##### 10.4.3 Readiness Influenced by Peer Recommendations and Online Reviews

##### 10.4.4 Barriers from Perceived Regulatory Uncertainty

#### 10.5 Post-Deployment ROI and Use Case Expansion

##### 10.5.1 Measurable Reduction in Cigarette Consumption Post-Switch

##### 10.5.2 Expansion into New Strength Variants for Heavy Users

##### 10.5.3 Retailer Margin Improvements from Higher Velocity SKUs

##### 10.5.4 Brand Loyalty Programs Driving Repeat Purchase Rates

### 11. USA Nicotine Pouch Market Future Size, 2025-2030

#### 11.1 By Value

#### 11.2 By Volume

#### 11.3 By Average Selling Price




## Go-To-Market Strategy Phase

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

### 1. Whitespace Analysis and Business Model Canvas

#### 1.1 Identifying Underserved Nicotine Strength Segments

#### 1.2 Mapping Regional Retail Gaps in the United States

#### 1.3 Evaluating Flavor Innovation White Space

#### 1.4 Assessing PMTA-Approved Competitor Coverage

### 2. Marketing and Positioning Recommendations

#### 2.1 Adult-Focused Messaging Emphasizing Harm Reduction

#### 2.2 Digital Campaigns Targeting Former Smokers

#### 2.3 Retail Point-of-Sale Education Programs

#### 2.4 Youth Prevention Compliance Branding

### 3. Distribution Plan

#### 3.1 Convenience Store Chain Prioritization

#### 3.2 Specialty Tobacco Outlet Partnerships

#### 3.3 E-Commerce Platform Integration Strategy

#### 3.4 Regional Wholesaler Agreements in High-Growth States

### 4. Channel and Pricing Gaps

#### 4.1 Premium vs. Value Tier Pricing Analysis

#### 4.2 Online vs. Offline Channel Margin Differentials

#### 4.3 Promotional Intensity Benchmarking

#### 4.4 Regional Pricing Disparities Across the United States

### 5. Unmet Demand and Latent Needs

#### 5.1 Demand for Higher Nicotine Strengths in Specific Demographics

#### 5.2 Need for Extended Flavor Shelf Life in Humid Regions

#### 5.3 Requirement for Clear PMTA Status Labeling

#### 5.4 Interest in Subscription-Based Direct Delivery Models

### 6. Customer Relationship

#### 6.1 Loyalty Programs for Repeat Adult Purchasers

#### 6.2 Retailer Training on Product Differentiation

#### 6.3 Post-Purchase Support via Digital Channels

#### 6.4 Feedback Loops from End-User Surveys

### 7. Value Proposition

#### 7.1 Smoke-Free Nicotine Delivery with Reduced Odor

#### 7.2 Wide Range of Strengths and Flavors for Personalization

#### 7.3 Domestic Manufacturing for Supply Reliability

#### 7.4 Compliance with Adult Targeting Standards

### 8. Key Activities

#### 8.1 Securing Additional PMTA Marketing Orders

#### 8.2 Building Retailer Education Networks

#### 8.3 Scaling Domestic Production Capacity

#### 8.4 Monitoring State Regulatory Developments

### 9. Entry Strategy Evaluation

#### 9.1 Domestic Market Entry Strategy

##### 9.1.1 Focus on PMTA-Approved Product Launches in Key States

##### 9.1.2 Partnership with National Convenience Chains

##### 9.1.3 Targeted Digital Marketing to Adult Nicotine Users

##### 9.1.4 Regional Test Markets in High-Growth Areas

#### 9.2 Export Entry Strategy

##### 9.2.1 Leveraging United States Manufacturing for Sweden and Denmark Markets

##### 9.2.2 Compliance Alignment with EU Tobacco Product Directive

##### 9.2.3 Distribution Partnerships in the United Kingdom and Germany

##### 9.2.4 Regulatory Pathway Analysis for Canada Market Entry

### 10. Entry Mode Assessment

#### 10.1 Joint Venture with Established Tobacco Players

#### 10.2 Direct Distribution Agreements with Retail Chains

#### 10.3 Licensing of PMTA-Approved Formulations

#### 10.4 Greenfield Manufacturing Expansion in Priority Regions

### 11. Capital and Timeline Estimation

#### 11.1 Initial Investment for PMTA Submissions and Approvals

#### 11.2 Timeline for Retail Rollout Across the United States

#### 11.3 Working Capital Requirements for Inventory Buildup

#### 11.4 Projected Break-Even Analysis by Channel

### 12. Control vs Risk Trade-Off

#### 12.1 Balancing Direct Control Over Marketing Compliance

#### 12.2 Risk Mitigation Through Authorized Manufacturer Partnerships

#### 12.3 Supply Reliability vs. Cost of Domestic Capacity

#### 12.4 Regulatory Change Exposure in Multi-State Operations

### 13. Profitability Outlook

#### 13.1 Gross Margin Projections by Strength Tier

#### 13.2 Channel-Specific Contribution Margins

#### 13.3 Impact of Promotional Intensity on Net Realization

#### 13.4 Long-Term ROI from PMTA Portfolio Expansion

### 14. Potential Partner List

#### 14.1 National Convenience Retailers

#### 14.2 Regional Tobacco Wholesalers

#### 14.3 E-Commerce Nicotine Platforms

#### 14.4 Contract Manufacturing Organizations

### 15. Execution Roadmap

#### 15.1 Phased Plan for Market Entry

##### 15.1.1 Market Setup

##### 15.1.2 Market Entry

##### 15.1.3 Growth Acceleration

##### 15.1.4 Scale and Stabilize

#### 15.2 Key Activities and Milestones

##### 15.2.1 Complete PMTA Submissions for Core SKUs

##### 15.2.2 Secure Initial Retail Placements in Top 10 States

##### 15.2.3 Launch Adult-Targeted Digital Awareness Campaign

##### 15.2.4 Achieve 5% Retail Share in Priority Channels




## Survey Phase

Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.

### 1. Research Design and Sample Architecture

#### 1.1 Research Objectives and Scope

#### 1.2 Sample Size Rationale and Representation

#### 1.3 Customer Cohort Definitions

#### 1.4 Geographic Coverage — Priority Metros and Tier 2/3 Cities

### 2. Data Collection Methodology

#### 2.1 Structured Interview Framework (50 In-Depth Interviews)

##### 2.1.1 Interview Guide and Question Design

##### 2.1.2 Respondent Recruitment and Screening Criteria

##### 2.1.3 Interview Execution and Quality Control

##### 2.1.4 Qualitative Coding and Insight Extraction

#### 2.2 Online Survey Design (200 Structured Surveys)

##### 2.2.1 Survey Instrument and Attribute Coverage

##### 2.2.2 Platform Selection and Distribution Channels

##### 2.2.3 Response Validation and Data Cleaning

##### 2.2.4 Statistical Significance and Margin of Error

### 3. Customer Cohort Profiles

#### 3.1 Cohort 1 — Large Enterprise End Users

##### 3.1.1 Cohort Definition and Size

##### 3.1.2 Key Demand Attributes

##### 3.1.3 Purchase Decision Drivers

##### 3.1.4 Represented Sample Size and Metro Distribution

#### 3.2 Cohort 2 — Mid-Size Enterprise End Users

##### 3.2.1 Cohort Definition and Size

##### 3.2.2 Key Demand Attributes

##### 3.2.3 Purchase Decision Drivers

##### 3.2.4 Represented Sample Size and City Distribution

#### 3.3 Cohort 3 — Small and Emerging Enterprise End Users

##### 3.3.1 Cohort Definition and Size

##### 3.3.2 Key Demand Attributes

##### 3.3.3 Purchase Decision Drivers

##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution

#### 3.4 Cohort 4 — Institutional and Government End Users

##### 3.4.1 Cohort Definition and Size

##### 3.4.2 Key Demand Attributes

##### 3.4.3 Procurement and Compliance Drivers

##### 3.4.4 Represented Sample Size and Regional Distribution

### 4. Demand Attributes Analysis

#### 4.1 Macroeconomic and Sectoral Growth Influences on Demand

##### 4.1.1 GDP and Industrial Output Linkages

##### 4.1.2 Urbanization and Infrastructure Expansion Impact

##### 4.1.3 Capital Investment Cycles and Procurement Timing

##### 4.1.4 Export and Import Dependency on USA Nicotine Pouch Market

#### 4.2 End-User Behavior and Consumption Patterns

##### 4.2.1 Frequency and Volume of Purchases

##### 4.2.2 Seasonal and Cyclical Demand Variations

##### 4.2.3 Brand Loyalty vs. Price Sensitivity Trade-Off

##### 4.2.4 Switching Triggers and Retention Factors

#### 4.3 Pricing Perception and Value Assessment

##### 4.3.1 Willingness to Pay Across Cohorts

##### 4.3.2 Price Benchmarking Against Substitutes

##### 4.3.3 Regional Pricing Disparities

##### 4.3.4 Total Cost of Ownership Perception

#### 4.4 Quality, Safety, and Compliance Expectations

##### 4.4.1 Quality Standards and Certification Requirements

##### 4.4.2 Safety and Regulatory Compliance Awareness

##### 4.4.3 Perception of Domestic vs. Imported Offerings

##### 4.4.4 After-Sales Service and Support Expectations

#### 4.5 Cultural, Regional, and Contextual Demand Factors

##### 4.5.1 Regional Industry Clusters and Demand Hotspots

##### 4.5.2 Cultural and Operational Norms Influencing Procurement

##### 4.5.3 Peer Influence and Industry Association Impact

##### 4.5.4 Digital Adoption and E-Procurement Readiness

#### 4.6 Marketing, Awareness, and Channel Influence

##### 4.6.1 Impact of Trade Shows, Exhibitions, and Industry Events

##### 4.6.2 Role of Digital Marketing and Online Platforms

##### 4.6.3 Distributor and Channel Partner Influence on Purchase

##### 4.6.4 OEM and System Integrator Partnership Impact

### 5. Unmet Needs and Latent Demand Signals

#### 5.1 Identified Gaps Between Current Supply and User Expectations

#### 5.2 Latent Demand in Underpenetrated Segments

#### 5.3 Willingness to Adopt New Formats or Technologies

#### 5.4 Pain Points Surfaced Across Cohorts

### 6. Key Findings and Strategic Implications

#### 6.1 Top Demand Drivers Ranked by Cohort

#### 6.2 Barriers to Purchase and Adoption

#### 6.3 High-Priority Customer Segments for Market Entry

#### 6.4 Recommendations for Product, Pricing, and Channel Strategy

### Disclaimer

### Contact Us